This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Charlotte, NC-based Albemarle Corporation is a premier specialty chemicals company with leading positions in attractive end markets globally. It is a leading producer of highly-engineered specialty chemicals geared to meet customer requirements across a bevy of end markets including petroleum refining, consumer electronics, energy storage, construction and automotive.
Is Trending Stock Albemarle Corporation (ALB) a Buy Now?
by Zacks Equity Research
Zacks.com users have recently been watching Albemarle (ALB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Albemarle's Earnings & Revenues Surpass Estimates in Q2
by Zacks Equity Research
ALB tops Q2 earnings estimates despite a 7% revenue dip, as lower lithium prices weigh on results.
Albemarle (ALB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Albemarle (ALB) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Albemarle (ALB) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of +113.25% and +6.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Albemarle to Post Q2 Earnings: What's in the Cards for the Stock?
by Zacks Equity Research
ALB's Q2 earnings are likely to reflect gains from cost cuts amid pressure from weak lithium prices.
Earnings Preview: Air Products and Chemicals (APD) Q3 Earnings Expected to Decline
by Zacks Equity Research
Air Products and Chemicals (APD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Albemarle (ALB) Q2 Earnings Expected to Decline
by Zacks Equity Research
Albemarle (ALB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Albemarle Corporation (ALB) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Albemarle (ALB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Albemarle (ALB) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
Albemarle (ALB) concluded the recent trading session at $77.07, signifying a +1.76% move from its prior day's close.
Albemarle (ALB) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed at $70.98 in the latest trading session, marking a -4.43% move from the prior day.
Strength Seen in Albemarle (ALB): Can Its 7.2% Jump Turn into More Strength?
by Zacks Equity Research
Albemarle (ALB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Albemarle Corporation (ALB) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Albemarle (ALB). This makes it worthwhile to examine what the stock has in store.
Albemarle (ALB) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
In the most recent trading session, Albemarle (ALB) closed at $67.21, indicating a -1.15% shift from the previous trading day.
Why Investors Need to Take Advantage of These 2 Basic Materials Stocks Now
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Want Better Returns? Don?t Ignore These 2 Basic Materials Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Albemarle (ALB) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
Albemarle (ALB) concluded the recent trading session at $64.95, signifying a +1.88% move from its prior day's close.
Albemarle (ALB) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Albemarle (ALB) reached $57.82 at the closing of the latest trading day, reflecting a +2.05% change compared to its last close.
Investors Heavily Search Albemarle Corporation (ALB): Here is What You Need to Know
by Zacks Equity Research
Albemarle (ALB) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
3 Diversified Chemical Stocks to Watch Amid Demand Headwinds
by Anindya Barman
Soft demand in specific markets and the sluggishness in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. DD, ALB and KRO are poised to navigate the industry challenges.
Albemarle (ALB) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
In the most recent trading session, Albemarle (ALB) closed at $65.08, indicating a +1.37% shift from the previous trading day.
Here is What to Know Beyond Why Albemarle Corporation (ALB) is a Trending Stock
by Zacks Equity Research
Albemarle (ALB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Albemarle (ALB) Registers a Bigger Fall Than the Market: Important Facts to Note
by Zacks Equity Research
Albemarle (ALB) reachead $58.64 at the closing of the latest trading day, reflecting a -1.78% change compared to its last close.
Albemarle (ALB) Down 3.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Trending Stock Albemarle Corporation (ALB) a Buy Now?
by Zacks Equity Research
Albemarle (ALB) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Albemarle Corporation (ALB) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Albemarle (ALB) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.